|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flow from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operations: | |||||
| Depreciation and amortization | |||||
| Non cash lease expense | |||||
| Gain on amortization of licensing obligation | |||||
| Provision for credit losses | |||||
| Provision for inventory obsolescence | |||||
| Fair value adjustment of warrants | |||||
| Change in fair value of derivative liability | |||||
| Inventory reserve for obsolescence | |||||
| Inventory impairment | |||||
| Goodwill impairment | |||||
| Impairment of preferred stock investment | |||||
| Loss on issuance of common stock to Yorkville in connection with the Side Letter | |||||
| Loss on issuance of common stock in connection with the settlement of debt | |||||
| Issuance of warrants for Strategic Advisory Agreement | |||||
| Issuance of common stock due to Strategic Advisory Agreement | |||||
| Loss on issuance of convertible note with warrants | |||||
| Issuance of warrants to preferred stockholders in consideration of forbearance agreement | |||||
| Gain on forgiveness of interest | |||||
| Share-based compensation expense | |||||
| Change in fair value of contingent consideration | |||||
| Issuance of common stock relating to Yorkville debt extension | |||||
| Acquired in-process research and development | |||||
| Issuance of common stock for stem-cells to be used in research and development | |||||
| Director fees paid with RSU’s | |||||
| Issuance of common stock to Palantir as consideration for settlement agreement | |||||
| Issuance of common stock to Yorkville for debt extension and SEPA commitment fee | |||||
| Issuance of common stock as compensation expense | |||||
| Discounts arising from RWI loan arrangement - related party | |||||
| Fair value of warrant modification for professional services | |||||
| Issuance of common stock for consulting expense | |||||
| Change in fair value of contingent stock consideration | |||||
| Loss on extinguishment of debt | |||||
| Change in fair value of debt | |||||
| Non cash interest expense | |||||
| Other, net | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventory | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Accrued expenses and other liabilities | |||||
| Right-of-use assets and lease liabilities | |||||
| Accrued R&D software | |||||
| Lease liabilities | |||||
| Deferred income tax liabilities | |||||
| Deferred revenue | |||||
| Net cash used in operating activities | |||||
| Cash flow from investing activities: | |||||
| Capital expenditures | |||||
| Rebound asset acquisition | |||||
| Purchase of acquired in-process research and development | |||||
| Proceeds from Sanuwave convertible note receivable | |||||
| Net cash provided by investing activities | |||||
| Cash flow from financing activities: | |||||
| Proceeds from RWI senior secured bridge loan and warrants - related party | |||||
| Transaction costs related to the issuance of promissory notes with warrants | |||||
| Proceeds from Issuance of promissory notes with warrants | |||||
| Proceeds from warrants and short-term debt - related parties | |||||
| Proceeds from issuance of short-term debt - unaffiliated | |||||
| Repayment of short-term debt - unaffiliated | |||||
| Proceeds from the sale of common stock in ATM offering | |||||
| Payment of SEPA commitment fee | |||||
| Repayments of short-term debt - related parties | |||||
| Proceeds from PIPE financings | |||||
| Net proceeds from offerings of equity securities | |||||
| Proceeds from the sale of common stock and warrants in July 2025 PIPE | |||||
| Proceeds from related party note with KTL Warrant | |||||
| Proceeds from the exercise of stock options | |||||
| Cash proceeds from merchant cash advance | |||||
| Repayment of merchant cash advance | |||||
| Proceeds from the exercise of warrants by Dragasac | |||||
| Repayment of short-term debt - related party | |||||
| Proceeds from issuance of senior secured C.V. Starr bridge loan and warrants - related party | |||||
| Proceeds from other short-term debt | |||||
| Proceeds from other short-term debt - related party | |||||
| Proceeds from issuance of preferred stock with warrants in PIPE Offering | |||||
| Transaction costs from issuing of preferred stock with warrants in PIPE Offering | |||||
| Tax withholding on vesting of restricted stock units | |||||
| Proceeds from registered direct offering | |||||
| Repayment of related party notes | |||||
| Net cash provided by financing activities | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of year | |||||
| Cash, cash equivalents and restricted cash at end of year | |||||
| Supplemental disclosure of cash flow information: | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes | |||||
| Supplemental non-cash investing and financing activities: | |||||
| Residual fair value of warrants issued with promissory notes | |||||
| Reclass of redemption value of preferred shares from equity to liability | |||||
| Conversion of unsecured senior convertible note | |||||
| Conversion of Yorkville convertible note | |||||
| Common stock issued for short-term debt conversion | |||||
| Issuance of warrants on senior secured bridge loans | |||||
| Reduction of right-of-use assets and associated lease liability due to lease modification | |||||
| Exchange of IP assets for license obligation | |||||
| Preferred stock received for product purchase credits | |||||
| Property and equipment included in accounts payable and accrued expenses | |||||
| Reclassification of RWI Bridge warrants from liability classified to equity classified | |||||
| Reclassification of November 2024 Purchaser and Placement Agent warrants from liability classified to equity classified | |||||
| Reclassification of KTL Warrants from liability classified to equity classified | |||||
| Issuance of RWI warrants and extinguishment of promise to issue warrants liability | |||||
| Deemed dividend relating to inducement of Dragasac warrants | |||||
| Settlement of contingent stock consideration liability | |||||
| Paid-in kind preferred stock dividends | |||||
| Fair value of bifurcated derivative liability associated with Preferred Stock issuance | |||||
| Modification of C.V. Starr warrants in connection with forbearance | |||||
| Issuance of RWI warrants in connection with forbearance | |||||
| Issuance of warrants on senior secured bridge loan | |||||
| Reduction of right-of-use assets and associated lease liabilities - operating due to lease modification | |||||
| PIPE related costs included in accrued expenses | |||||
| Interest accrued on senior secured loans within long-term debt - related parties | |||||
| Contingent consideration accrued in connection with Rebound asset acquisition | |||||
| Inventory acquired in connection with Rebound asset acquisition | |||||
| Reclassification of warrants from liability classified to equity classified | |||||
| Assumption of short-term debt - unaffiliated by related party | |||||
Loading...